Symbol | Exchange | Currency |
|---|
Cocrystal Pharma, Inc. (Nasdaq: COCP) reports financial results for the three months ended March 31, 2022, and provides updates on its antiviral pipeline, upcoming milestones and...
Investing.com – U.S. stocks were mixed after the close on Wednesday, as gains in the Oil & Gas, Basic Materials and Telecoms sectors led shares higher while losses in the...
Investing.com – U.S. stocks were lower after the close on Thursday, as losses in the Oil & Gas, Technology and Basic Materials sectors led shares lower. At the close in NYSE, the...
Shares of Cocrystal Pharma, Inc. (NASDAQ:COCP) surged 18.6% after the company announced plans to advance its coronavirus program.Shares of Compugen Ltd. (NASDAQ:CGEN) gained...
Alpha Pro Tech (NYSE:APT), which is a manufacturer of masks and containment gowns, was up 2.86, or 40%, to 10.00, on 19 million shares on Tuesday. This stock went in Jan from...
Cocrystal Pharma, Inc. is a biotechnology company. The Company focuses on developing antiviral therapeutics that inhibit the essential viral replication function of RNA viruses causing acute and chronic viral diseases. The Company focuses on treating influenza virus, coronavirus, hepatitis C virus (HCV) and norovirus infections by discovering and developing drug candidates targeting the viral replication process. The Company uses computational methods to screen and design product candidates using cocrystal structural information. Its development pipeline includes CC-31244 and CC-42344. The Company’s CC-31244 is a pan-genotypic inhibitor of NS5B polymerase for the treatment of hepatitis C infection. The Company’s CC-42344 is a PB2 inhibitor for the treatment of influenza A infection. Its pipeline also includes CDI-45205 for the treatment of coronavirus. It has also developed chemical libraries consisting of non-nucleoside inhibitors, metal-binding inhibitors, and drug-like fragments.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Neutral | Buy | Strong Sell |
| Technical Indicators | Sell | Neutral | Neutral | Strong Buy | Strong Sell |
| Summary | Strong Sell | Neutral | Neutral | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 174.83 | 175.07 | 173.96 | +0.98 | +0.56% | 362.60K | NASDAQ | |||
| 258.60 | 258.70 | 256.45 | +1.80 | +0.70% | 301.10K | NYSE | |||
| 145.09 | 145.94 | 144.50 | -0.18 | -0.12% | 912.90K | NYSE | |||
| 86.67 | 87.90 | 86.19 | -3.36 | -3.73% | 1.11M | NYSE | |||
| 8.22 | 8.48 | 8.21 | -0.20 | -2.40% | 945.13K | NYSE | |||
| 39.80 | 44.29 | 39.15 | -17.44 | -30.47% | 14.15M | NASDAQ | |||
| 30.89 | 31.16 | 30.72 | +0.50 | +1.65% | 1.82M | NYSE | |||
| 1.1498 | 1.18 | 1.07 | +0.0498 | +4.53% | 180.77K | NYSE | |||
| 85.50 | 87.35 | 85.01 | +0.31 | +0.36% | 145.77K | NYSE | |||
| 3.43 | 3.51 | 3.415 | -0.040 | -1.15% | 2.52M | NYSE | |||
| 8.104 | 9.127 | 7.86 | -5.876 | -42.03% | 12.34M | NASDAQ | |||
| 44.84 | 45.69 | 44.65 | -0.16 | -0.36% | 565.23K | NYSE | |||
| 5.035 | 5.09 | 5.01 | -0.055 | -1.08% | 434.93K | NYSE | |||
| 1.195 | 1.24 | 1.17 | -0.0450 | -3.63% | 1.55M | NYSE | |||
| 155.29 | 155.50 | 154.33 | -0.70 | -0.45% | 141.41K | NYSE |